News
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
S&P 500, Dow Jones, and Nasdaq-- will remain close on Friday. New York Stock Exchange, Wall Street will be observe holiday on ...
Netflix scored $6.61 EPS ($2.9 billion net income) and $10.54 billion last quarter, besting consensus analyst estimates ...
U.S. stocks closed mixed on Thursday — the final session of trade this week ahead of the long Easter weekend — while booking weekly losses. The blue-chip Dow Jones Industrial Average was pulled lower ...
US stock futures traded flat on the heels of a bruising day on Wall Street that underscored fears over the economic impact of ...
The stock of Taiwan Semiconductor Manufacturing ( TSM 0.13%) is seeing modest gains Thursday following the company's recent quarterly release. The semiconductor fabrication leader's share price was up ...
Wall Street stocks ended mixed on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade ...
5h
Zacks Investment Research on MSN3 Key Reasons to Buy Alibaba Stock Beyond its 25.9% Year-to-Date SurgeAlibaba Group BABA shares have already gained an impressive 25.9% year to date, outperforming the Zacks Internet-Commerce ...
The gold stocks continued rallying this week, with GDX hitting $50.50 Tuesday and running $52.50 Wednesday morning as I pen ...
Mar quarter consolidated results on Thursday, April 17. The Infosys ADR shares on the New York Stock Exchange dropped over 4% ...
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results